Tom is a writer and aspiring flâneur who today provides creative services to mostly technology-centered clients. He led the Encarta team at Microsoft and, long ago, put KZAM radio on the air.
What does the path to vaccine-enabled herd immunity look like for the United States? It will look like a track set up for hurdlers. If we clear them all, we can win full normalcy. If we clear most, we might be able to manage a more rickety normalcy.
It appears that, of the 94 cases, about 8 were from vaccine recipients, and 86 were from placebo recipients. That’s a great ratio, but still very small numbers. The FDA wants to see the numbers after they’ve looked at 164 confirmed cases.
Control of the Senate is riding on these two races. Expect money to shower down on Georgia for the next two months; it will be sixty days of rainy nights.
Last night, many people who never watch Fox got a full dose of Trump, and suddenly realized that he's not just the butt of their friend's jokes, he's a uniquely dangerous person who could do untold damage in the next four years.
I imagine Trump's hard-core base enjoyed seeing Trump do his thing, which in this case was to display dominance behavior as best he could over Biden and Wallace. He was in his game, but he didn't knock Biden off his game.
Despite this monumental effort, there’s a lot we don’t know yet about these potential vaccines, which means there’s a lot we don’t know about just how much benefit we’ll get from them. Our ignorance can be usefully organized into four categories: efficacy, durability, safety, and scalability.
The results were unsettling, to say the least: “Cardiac magnetic resonance imaging revealed cardiac involvement in 78 patients (78%) and ongoing myocardial inflammation in 60 patients (60%), which was independent of preexisting conditions, severity and overall course of the acute illness, and the time from the original diagnosis.”